Cellaria launches new tumor modeling platform

By Kate Madden Yee, The Science Advisory Board contributing writer

November 10, 2021 -- Cellaria has launched a new tumor modeling platform that includes a panel of cell culture media for growing cell types, an extracellular neutral collagen matrix, and protocols for testing new drug compounds.

The platform is based on the company's Renaissance Essential Media -- which can be used with lymphocytes, mesenchymal stromal cells, normal cells, and cancer-associated fibroblasts -- and patient-matched cell types that can be combined in organoid models of tumor metastatic nodes and solid tumors. It also consists of the company's Jellagen Extracellular Matrix, a neutral 3D cell culture scaffold, Cellaria said.

Cellaria launches cell lines for lung cancer therapies
Citing a successful cohort study of patients, Cellaria has launched five new lung cancer cell models to support the development of more effective and...
Cellaria, BioLamina partner on new cell culture models
Cellaria and BioLamina have announced that they plan to collaborate on developing new cell culture models for cancer research, tissue modeling, drug screening,...
Cellaria introduces new models to study pancreatic cancer
Cellaria has launched three new cell lines for pancreatic cancer that it hopes will improve patient care by improving the value of in vitro methods of...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter